BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37287312)

  • 1. PlmCas12e (CasX2) cleavage of CCR5: impact of guide RNA spacer length and PAM sequence on cleavage activity.
    Armstrong DA; Hudson TR; Hodge CA; Hampton TH; Howell AL; Hayden MS
    RNA Biol; 2023 Jan; 20(1):296-305. PubMed ID: 37287312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAS12e (CASX2) CLEAVAGE OF CCR5: IMPACT OF GUIDE RNA LENGTH AND PAM SEQUENCE ON CLEAVAGE ACTIVITY.
    Armstrong DA; Hudson TR; Hodge CA; Hampton TH; Howell AL; Hayden MS
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position of Deltaproteobacteria Cas12e nuclease cleavage sites depends on spacer length of guide RNA.
    Selkova P; Vasileva A; Pobegalov G; Musharova O; Arseniev A; Kazalov M; Zyubko T; Shcheglova N; Artamonova T; Khodorkovskii M; Severinov K; Fedorova I
    RNA Biol; 2020 Oct; 17(10):1472-1479. PubMed ID: 32564655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
    Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
    Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
    Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
    Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional Degradation of DNA Cleavage Products Catalyzed by CRISPR/Cas9.
    Stephenson AA; Raper AT; Suo Z
    J Am Chem Soc; 2018 Mar; 140(10):3743-3750. PubMed ID: 29461055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Efficiency for Biallelic Mutations of the
    Lin D; Scheller SH; Robinson MM; Izadpanah R; Alt EU; Braun SE
    CRISPR J; 2021 Feb; 4(1):92-103. PubMed ID: 33616448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
    Heler R; Samai P; Modell JW; Weiner C; Goldberg GW; Bikard D; Marraffini LA
    Nature; 2015 Mar; 519(7542):199-202. PubMed ID: 25707807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity.
    Cradick TJ; Fine EJ; Antico CJ; Bao G
    Nucleic Acids Res; 2013 Nov; 41(20):9584-92. PubMed ID: 23939622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.
    Moreb EA; Hutmacher M; Lynch MD
    CRISPR J; 2020 Dec; 3(6):550-561. PubMed ID: 33346713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system.
    Zhang B; Lin J; Perčulija V; Li Y; Lu Q; Chen J; Ouyang S
    Nucleic Acids Res; 2022 Nov; 50(20):11820-11833. PubMed ID: 36321657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmable RNA recognition and cleavage by CRISPR/Cas9.
    O'Connell MR; Oakes BL; Sternberg SH; East-Seletsky A; Kaplan M; Doudna JA
    Nature; 2014 Dec; 516(7530):263-6. PubMed ID: 25274302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM.
    Tang LC; Gu F
    Yi Chuan; 2020 Mar; 42(3):236-249. PubMed ID: 32217510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
    Karvelis T; Gasiunas G; Siksnys V
    Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
    Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
    J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palindromic target site identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by adopting CRISPR-Cas technique.
    Ghosh N; Saha I; Sharma N
    Gene; 2022 Apr; 818():146136. PubMed ID: 34999179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene disruption by CRISPR/xCas9 system in Drosophila melanogaster.
    Ni XY; Zhou ZD; Huang J; Qiao X
    Arch Insect Biochem Physiol; 2020 May; 104(1):e21662. PubMed ID: 32027059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
    Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
    Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.